Skip to content

A study comparing how dexmedetomidine affects the results of shoulder and arm nerve block when used with two different numbing medicines levobupivacaine and ropivacaine

Effect Of Dexmedetomidine As An Adjuvant On Characteristics Of Ultrasound Guided Supraclavicular Brachial Plexus Block With Levobupivacaine And Ropivacaine A Comparative Study - NIL

Status
Active, not recruiting
Phases
Unknown
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2025/12/098558
Enrollment
70
Registered
2025-12-05
Start date
Unknown
Completion date
Unknown
Last updated
2025-12-08

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: O- Medical and Surgical Health Condition 2: M218- Other specified acquired deformities of limbs Health Condition 3: M654- Radial styloid tenosynovitis [de Quervain] Health Condition 4: M652- Calcific tendinitis Health Condition 5: M651- Other infective (teno)synovitis Health Condition 6: M662- Spontaneous rupture of extensor tendons Health Condition 7: M663- Spontaneous rupture of flexor tendons Health Condition 8: M859- Disorder of bone density and structure, unspecified Hea

Interventions

Intervention1: Supraclavicular Brachial Plexus Block: Use of 22 gauge of Stimuplex needle and a linear ultrasound probe Control Intervention1: INJ ROPIVACAINE 0.5% INJ LEVOBUPIVACAINE 0.5% INJ DEXMEDE

Sponsors

Pacific Medical College And Hospital, Udaipur
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: American Society of Anesthesiologist Physical status 1 and 2. Scheduled for elective upper limb surgery under supraclavicular brachial plexus block.

Exclusion criteria

Exclusion criteria: Lack of patient consent. American Society of Anesthesiologist Physical status 3,4 or 5. Patient with anticipated difficult intubation, Mallampati grade 3 or 4. Any other comorbidities i.e. COPD, IHD, Hypertension, Diabetes Mellitus, Renal or Hepatic dysfunction. Allergic to Local Anesthetic drug. Cpagulation or bleeding disorder Brachia plexus injury

Design outcomes

Primary

MeasureTime frame
Rapid onset of brachial plexus blockTimepoint: 5 minutes

Secondary

MeasureTime frame
Prolongs the duration of brachial plexus blockTimepoint: more then 5 hours;Extended Postoperative analgesic timeTimepoint: more then 5 hours

Countries

India

Contacts

Public ContactDr Krishan Gopal Jangir

Pacific Medical College And Hospital

kg.jangir@gmail.com9983561298

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Feb 4, 2026